HIV vaccine design and the neutralizing antibody problem.
Burton
Dennis R
DR
Departments of Immunology and Molecular Biology, Scripps Research Institute, La Jolla, California, USA. burton@scripps.edu
Desrosiers
Ronald C
RC
Doms
Robert W
RW
Koff
Wayne C
WC
Kwong
Peter D
PD
Moore
John P
JP
Nabel
Gary J
GJ
Sodroski
Joseph
J
Wilson
Ian A
IA
Wyatt
Richard T
RT
D016915:AIDS Vaccines / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology; D015195:Drug Design; D000939:Epitopes / Q000737:chemistry / Q000276:immunology; D015483:HIV Antibodies / Q000276:immunology*; D015699:HIV Envelope Protein gp120 / Q000737:chemistry / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000737:chemistry / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008958:Models, Molecular; D009500:Neutralization Tests
D016915:AIDS Vaccines; D000911:Antibodies, Monoclonal; D000939:Epitopes; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41